Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
---|
08/05/1987 | EP0230575A2 Medicament active against tumours, containing hexadecylphosphocholine |
08/05/1987 | EP0230574A2 Pharmaceutical compositions against infections caused by LAV/HTLV III virus and the use thereof |
08/04/1987 | US4684723 Method of separating proteins from aqueous solutions |
08/04/1987 | US4684716 Vasopressin antagonists |
08/04/1987 | US4684660 Mercaptoacyldepeptides |
08/04/1987 | US4684645 Gastrointestinal and nervous system disorders |
08/04/1987 | US4684625 Method for enhancing the anti-infective activity of muramyldipeptide derivatives |
08/04/1987 | US4684624 Method of treating cerebral ischemia |
08/04/1987 | US4684623 Use of tumor necrosis factor as a weight regulator |
08/04/1987 | US4684622 Compositions and methods for producing vasodilation and antioxytocic activity |
08/04/1987 | US4684621 Oligopeptides |
08/04/1987 | US4684620 Cyclic polypeptides having mu-receptor specificity |
08/04/1987 | US4684520 Coenzyme q10 and phospholiped mixture |
08/04/1987 | CA1225031A1 Method for improving milk production in lactating ruminants |
07/30/1987 | WO1987004459A1 Retrovirus of the hiv-2 type susceptible of inducing aids, and its antigenic and nucleic constituents |
07/30/1987 | WO1987004440A1 Heptanoyl-glu-asp-ala-amino acid immunostimulants |
07/30/1987 | WO1987004351A1 Method for the diagnosis and treatment of inflammation |
07/30/1987 | WO1987004349A1 Peptide analogs |
07/30/1987 | WO1987004348A1 Acylated cyanamide composition |
07/30/1987 | WO1987004347A1 Solubilization of hydrophobic materials using lysophospholipid |
07/29/1987 | EP0230266A2 Functionalized peptidyl aminodiols and -triols |
07/29/1987 | EP0230264A2 Pharmaceutical composition for nasal application, process for its preparation and its use |
07/29/1987 | EP0230242A2 Substituted derivatives of 4-amino-3-hydroxy-butyric acid, process for their production, medicines containing them, and their use |
07/29/1987 | EP0230222A1 Expression of HTLV-III gag-Gene |
07/29/1987 | EP0230166A1 Diagnostic reagents |
07/29/1987 | EP0230151A2 Cholecystokinin antagonists |
07/29/1987 | EP0230119A1 Cloning, characterization and expression of bovine gamma interferon |
07/29/1987 | EP0230107A1 Mammalian interleukin-4 |
07/29/1987 | EP0230052A2 Immunoamplifiers and related Compositions |
07/29/1987 | EP0229998A2 Fusion proteins with an eukaryotic ballast sequence |
07/29/1987 | EP0229811A1 Monoclonal antibodies and their use |
07/29/1987 | CN85106191A Production of hemopoietin |
07/28/1987 | US4683292 Immunotherapeutic polypeptide agents which bind to lymphocyte immunoglobulin FC receptors |
07/28/1987 | US4683291 Polypeptide anticoagulants |
07/28/1987 | US4683238 2,3,4,9-tetrahydro beta carboline derivatives, useful as antihypertensive agents |
07/28/1987 | US4683221 Lymphocyte-activating polypeptides |
07/28/1987 | US4683220 Hypotensive agents, oligopeptides |
07/28/1987 | CA1224735A1 Cloning system for kluyveromyces species |
07/28/1987 | CA1224622A1 Photochemical decontamination treatment of whole blood or blood components |
07/23/1987 | DE3601032A1 Polypeptides with anticoagulant affect, process for their preparation or isolation, their use and compositions containing these |
07/22/1987 | EP0229750A2 Human preproinsulin-like growth factor I |
07/22/1987 | EP0229723A2 Modified Beta 2-microglobulin |
07/22/1987 | EP0229667A2 Peptidylaminodiols |
07/22/1987 | EP0229564A1 Glycoproteins modified by oxidation followed by reduction, which inhibit ribosomes, production process and immunotoxines containing such a glycoprotein |
07/22/1987 | EP0229546A1 Carbohydrate perturbations of viruses or viral antigens and utilization for diagnostic, prophylactic and/or therapeutic applications |
07/22/1987 | EP0229165A1 Vaso-occlusive collagen composition and method |
07/22/1987 | EP0229146A1 Monoclonal antibodies and their use |
07/22/1987 | EP0229107A1 PROTECTIVE HUMAN MONOCLONAL ANTIBODIES TO $i(PSEUDOMONAS AERUGINOSA) EXOTOXIN A |
07/22/1987 | EP0116085B1 Interferon and interferon inducers combined with tobacco products |
07/22/1987 | EP0094412B1 Medical process and preparation |
07/21/1987 | US4681931 Partition, water-urea-anionic surfactant, 1-butanol-acetic acid-water |
07/21/1987 | US4681930 Immune interferon and a method for its extraction and purification |
07/21/1987 | US4681896 Pharmaceutical and dietary composition |
07/21/1987 | US4681871 Tyrosine-proline oligopeptides, analgesics |
07/21/1987 | US4681856 Hapten, antitumor |
07/21/1987 | US4681754 Counteracting cyclosporin organ toxicity |
07/21/1987 | CA1224435A1 Protein having cell growth stimulating action composition thereof and method for producing the same |
07/21/1987 | CA1224432A1 Dna sequences, recombinant dna molecules and processes for producing bovine growth hormone-like polypeptides in high yield |
07/16/1987 | WO1987004291A1 Word recognition in a speech recognition system using data reduced word templates |
07/16/1987 | WO1987004187A1 METHOD FOR PRODUCING FACTOR VIII:c-TYPE PROTEINS |
07/16/1987 | WO1987004185A1 Vaccines for human respiratory virus |
07/16/1987 | WO1987004184A1 Process for granulating enzyme |
07/16/1987 | WO1987004075A1 Pseudorabies virus vaccine |
07/16/1987 | WO1987004074A1 Use of growth hormone for nitrogen retention under hypocaloric conditions |
07/16/1987 | WO1987004073A1 Lymphocyte-activating polypeptides |
07/15/1987 | EP0229026A2 Therapeutic blood product, means and methods of preparing same |
07/15/1987 | EP0229016A2 Interleukin-2 compositions |
07/15/1987 | EP0228988A1 Treatment of thrombosis with fibrinolytics and prostacyclins |
07/15/1987 | EP0228975A1 Mixture of antibodies specific for lactic acid bacteria bacteriophages and its use in the detection and neutralization of these bacteriophages |
07/15/1987 | EP0228862A2 Stabilized human tissue plasminogen activator compositions |
07/15/1987 | EP0228833A2 Immunostimulant agents |
07/15/1987 | EP0228604A2 Isolation of a gene encoding human thyrotropin beta subunit |
07/15/1987 | EP0228452A1 Protein purification. |
07/15/1987 | EP0228404A1 Pentapeptides with cell growth regulatory effects and a process for the preparation thereof. |
07/15/1987 | CN86107809A Recombinant gene and use thereof |
07/15/1987 | CN86106774A Superoxide dismutase |
07/14/1987 | US4680392 Substituted caprolactam derivatives as antihypertensives |
07/14/1987 | US4680383 Monoclonal antibody to human T cells |
07/14/1987 | US4680382 Analogues of actinomycin D |
07/14/1987 | US4680338 Bifunctional linker |
07/14/1987 | US4680284 Rennin inhibitors, hypotensive agents |
07/14/1987 | US4680283 Lachrymators |
07/14/1987 | US4680276 Metal polypeptides |
07/14/1987 | US4680261 Process for producing interferon |
07/14/1987 | US4680260 Method for producing human leukocyte interferon alpha-2 |
07/14/1987 | US4680175 Interferon administration vehicles |
07/14/1987 | CA1224208A1 Sialic acid specific slug lectin |
07/14/1987 | CA1224172A1 Human endogenous cancer regulatory factor, process for preparing the same, pharmaceutical composition containing the same and human monocytic leukemia cell lines |
07/14/1987 | CA1224167A1 Preparation of secretin |
07/08/1987 | EP0228357A2 Prostate-derived growth factor |
07/08/1987 | EP0228243A1 Monoclonal antibodies having binding specificity to human prostate tumor-associated antigens and methods for employing the same |
07/08/1987 | EP0228018A2 GM-CSF protein, its derivatives, preparation of such proteins and their use |
07/08/1987 | EP0228015A2 Antibiotic a 40926 mannosyl aglycon |
07/08/1987 | EP0227834A1 Method for purifying an interferon |
07/08/1987 | EP0227827A1 Unduline and its fragmentation products, production process and utilization thereof |
07/08/1987 | EP0227810A1 Processes for producing uromodulin |
07/08/1987 | CN86107569A Selective chemical removal of protein amino-terminal residue |
07/07/1987 | USRE32455 A-21978 antibiotics and process for their production |
07/07/1987 | US4678808 Rapid acting intravenous emulsions of omega-3 fatty acid esters |
07/07/1987 | US4678751 Viral and neoplastic diseases |